Federal Register #FDA-2026-N-8087

FDA Requests Public Comment on Proposed Information Collection for Focus Groups and Interviews

The Food and Drug Administration (FDA), under the Department of Health and Human Services, is seeking public comment on a proposed information collection initiative. - Government Buyer: - Food and Drug Administration (FDA), Department of Health and Human Services - Scope of Request: - Collection of qualitative data via focus groups and in-depth interviews - Targeted participants include the general public, healthcare professionals, industry representatives, and other stakeholders related to FDA-regulated products - Products/Services Requested: - No physical products or OEMs involved - Service: Qualitative research (focus groups and interviews) - Estimated 12,000 respondents annually, each participating in one session - Average burden: 1.75 hours per response - Notable Requirements: - Research covers drugs, biologics, devices, food, tobacco products, and veterinary medicine - Input sought on necessity, methodology, and burden of the information collection - Approval requested for a three-year period to support baseline data collection - OEMs and Vendors: - No OEMs or vendors specified; this is an information gathering activity, not a product or service procurement

Description

The Food and Drug Administration (FDA) is seeking public comments on the proposed collection of information involving focus groups and in-depth individual interviews related to FDA-regulated products. These qualitative research tools are used to gather consumer attitudes, beliefs, motivations, and feelings to inform the development of quantitative studies and policy decisions. The collection targets members of the general public, healthcare professionals, industry, and other stakeholders related to FDA-regulated products. Comments on this information collection must be submitted by October 27, 2026.

View original listing